케어디엔엑스 (CDNA) 주가

케어디엔엑스(CDNA)는 NASDAQ에 상장된 Healthcare · Diagnostics & Research 기업입니다. 현재가 $54.30 (+0.04%), 시가총액 $1.05B, 52주 최저~최고 $11.57 ~ $22.42.

CareDx, Inc. provides solutions for improving outcomes for transplant patients and advancing organ health in the United States and internationally. The company provides AlloSure Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients; AlloMap Heart, a gene expression profiling solution for heart transplant patients; AlloSure Heart, a dd-cfDNA solution for heart transplant patients; and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. It also offers HeartCare, which provides information about distinct biological processes, such as immune quiescence, active injury, acute cellular rejection, and antibody mediated rejection; HistoMap Kidney, a sol

핵심 지표

• 현재가: $54.30 (+0.04%)
• 시가총액: $1.05B
• 52주 최저~최고: $11.57 ~ $22.42
• 섹터: Healthcare
• 산업: Diagnostics & Research
• 거래소: NASDAQ

케어디엔엑스의 재무제표, 목표주가, 기관투자자(13F) 보유 현황, 관련 뉴스는 BlackAll Trade에서 실시간으로 확인할 수 있습니다.

케어디엔엑스 재무 요약

애널리스트 전망

• 투자의견 컨센서스: 4.125

핵심 재무비율 · 수익성 · 성장성

• PBR (주가순자산비율): 3.60
• 순이익률: -0.02%
• 영업이익률: 0.02%

자주 묻는 질문